Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oncogene and patient prognosis].

H Ito1, E Tahara

  • 11st Dept. of Pathology, Hiroshima University School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coamplification of cyclin-d, hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas.

Oncology reports·2011
Same author

Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression.

Oncology reports·2011
Same author

Increased expression and phosphorylation of sh-ptp2 (syp) in human gastric carcinomas.

Oncology reports·2011
Same author

A splice variant of the c-met proto-oncogene is the predominant population expressed in human gastric mucosa and carcinoma.

Oncology reports·2011
Same author

Genetic abnormalities and expression of p53 in human colon carcinomas.

International journal of oncology·2011
Same author

Biologic effect of human hepatocyte growth-factor on human gastric-carcinoma cell-lines.

International journal of oncology·2011

Gene alterations, including oncogene amplification, are key to cancer development and progression. Analyzing these genetic changes, alongside tumor suppressor genes like p53, can improve patient prognosis and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Common malignancies develop through a stepwise accumulation of genetic alterations.
  • These alterations include changes in oncogenes and tumor suppressor genes.
  • Gene amplification is often a late-stage event in carcinogenesis.

Purpose:

  • To explore the role of gene alterations, particularly oncogene amplification, in cancer development and progression.
  • To investigate the correlation between specific oncogene amplifications and patient prognosis in various carcinomas.
  • To assess the potential clinical utility of combining gene amplification analysis with other genetic alterations, such as p53, for improved cancer management.

Summary:

  • Carcinogenesis involves a stepwise accumulation of gene alterations, with point mutations/deletions as early events and gene amplification as a late event.

Related Experiment Videos

  • Specific oncogene amplifications (e.g., erbB2, HST-1/INT-2, N-myc) are linked to patient prognosis in breast, ovarian, gastric, esophageal, and bladder cancers, as well as neuroblastoma.
  • Amplification of erbB1, though less frequent, also indicates a poorer prognosis in several cancer types.

    • Impact:

    • Understanding gene amplification patterns can refine prognostic assessments for cancer patients.
    • Combined analysis of gene amplification and other genetic markers (e.g., p53) may offer more comprehensive clinical information.
    • This knowledge can guide postoperative management strategies and improve patient outcomes in oncology.